Fortitude Advisory Group L.L.C. Harvard Bioscience Inc Transaction History
Fortitude Advisory Group L.L.C.
- $167 Million
- Q2 2025
Shares
2 transactions
Others Institutions Holding HBIO
# of Institutions
74Shares Held
23.2MCall Options Held
101KPut Options Held
22K-
Amh Equity LTD4.05MShares$2.06 Million2.46% of portfolio
-
Black Rock Inc. New York, NY2.84MShares$1.45 Million0.0% of portfolio
-
Harvey Partners, LLC Tarrytown, NY2.14MShares$1.09 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.85MShares$945,4840.0% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.5MShares$765,7690.03% of portfolio
About HARVARD BIOSCIENCE INC
- Ticker HBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 41,636,500
- Market Cap $21.2M
- Description
- Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...